- Aries Agro inaugurated relocated Unnano manufacturing unit with 1,01,400 MT capacity. It has reserves of Rs.299.16 cr. against equity of Rs.13 cr. FY26 PAT stood at Rs.38.37 cr. and dividend increased to 25% from 12%. Working capital cycle improved sharply from 89 days to 64 days. Stock looks attractive at Rs.330 against 52-week high of Rs.460.
- Debt-free Jenburkt Pharma has reserves of Rs.193 cr. against equity of Rs.4 cr. Q4FY26 PAT jumped 83% QoQ to Rs.10.85 cr. FY26 PAT stood at Rs.34.74 cr. with EPS of Rs.78.71. Dividend increased to 207% from 180%. PE of 13x, ROE of 20.4% and ROCE of 27.2% remain attractive. Stock can easily double at current valuations
- Mitsu Chem Plast announced capacity expansion at its Khalapur unit, adding 2,550 MT per year to enhance manufacturing capabilities.
- NIS Management reported FY26 total income of Rs.437 cr. and EBITDA growth of 12% YoY to Rs.34 cr., while Q4FY26 EBITDA surged 30% YoY to Rs.11 cr. on improved operational efficiency.
- Sathlokhar Synergys E&C Global secured additional orders worth Rs.125 cr. across India and Sri Lanka, taking FY27 confirmed order book to Rs.840.22 cr.
- Aries Agro inaugurated relocated Unnano manufacturing unit with 1,01,400 MT capacity. It has reserves of Rs.299.16 cr. against equity of Rs.13 cr. FY26 PAT stood at Rs.38.37 cr. and dividend increased to 25% from 12%. Working capital cycle improved sharply from 89 days to 64 days. Stock looks attractive at Rs.330 against 52-week high of Rs.460.
- Debt-free Jenburkt Pharma has reserves of Rs.193 cr. against equity of Rs.4 cr. Q4FY26 PAT jumped 83% QoQ to Rs.10.85 cr. FY26 PAT stood at Rs.34.74 cr. with EPS of Rs.78.71. Dividend increased to 207% from 180%. PE of 13x, ROE of 20.4% and ROCE of 27.2% remain attractive. Stock can easily double at current valuations
- Mitsu Chem Plast announced capacity expansion at its Khalapur unit, adding 2,550 MT per year to enhance manufacturing capabilities.
- NIS Management reported FY26 total income of Rs.437 cr. and EBITDA growth of 12% YoY to Rs.34 cr., while Q4FY26 EBITDA surged 30% YoY to Rs.11 cr. on improved operational efficiency.
- Sathlokhar Synergys E&C Global secured additional orders worth Rs.125 cr. across India and Sri Lanka, taking FY27 confirmed order book to Rs.840.22 cr.
- Rathi Steel and Power reported strong FY26 performance with revenue rising 42% YoY to Rs.716 cr. and PAT at Rs.13 cr., supported by 96% YoY surge in Q4FY26 profit.
- Premium Plast reported FY26 revenue of Rs.75.82 cr., net profit of Rs.6.87 cr. and EBITDA margin of 19.33%, reflecting healthy profitability.
- Chandan Healthcare reported strong FY26 performance with total income rising to Rs.280.67 cr., EBITDA up 31% YoY to Rs.56.84 cr. and PAT rising 22% YoY to Rs.27.06 cr. driven by diagnostics business growth.
- Rathi Steel and Power reported strong FY26 performance with revenue rising 42% YoY to Rs.716 cr. and PAT at Rs.13 cr., supported by 96% YoY surge in Q4FY26 profit.
- Premium Plast reported FY26 revenue of Rs.75.82 cr., net profit of Rs.6.87 cr. and EBITDA margin of 19.33%, reflecting healthy profitability.
- Chandan Healthcare reported strong FY26 performance with total income rising to Rs.280.67 cr., EBITDA up 31% YoY to Rs.56.84 cr. and PAT rising 22% YoY to Rs.27.06 cr. driven by diagnostics business growth.
